Year: 2024
Type: review
Abstract: ABSTRACT Human norovirus (HuNoV) is a major cause of acute gastroenteritis and foodborne diseases, affecting all age groups. Despite its clinical needs, no approved antiviral therapies are available. Since the discovery of HuNoV in 1972, studies on anti-norovirals, mechanism of HuNoV infection, viral inactivation, etc., have been hampered by the lack of a robust laboratory-based cultivation system for HuNoV. A recent breakthrough in the development of HuNoV cultivation systems has opened opportunities for researchers to investigate HuNoV biology in the context of de novo HuNoV infections. A tissue stem cell-derived human intestinal organoid/enteroid (HIO) culture system is one of those that supports HuNoV replication reproducibly and, to our knowledge, is most widely distributed to laboratories worldwide to study HuNoV and develop therapeutic strategies. This review summarizes recently developed HuNoV cultivation systems, including HIO, and their use in antiviral studies.
Source: Journal of Virology
DOI: 10.1128/jvi.01663-23
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1954461984, G208685589, G2228610084, G2993110006, Research on activation of human norovirus by intestinal factors, G4188048614, G5078627213, Characterization of enterovirus 3A protein disrupting endoplasmic reticulum homeostasis, G6511169120, G7104713884, Comprehensive utilization of innovative virus indicators for microbial water safety, 感染効率と汎用性の高いfirst classのヒトノロウイルス培養細胞系の樹立
OpenAlex ID: W4392893158
